Skip to content

Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study

Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study for Evaluation of Efficacy and Safety of Etanercept Versus Intra-articular Steroid Injection in Acute Synovitis

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00522184
Enrollment
34
Registered
2007-08-29
Start date
2005-02-01
Completion date
2006-11-01
Last updated
2026-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis

Keywords

intra-articular injection, acute synovitis, etanercept

Brief summary

Intra-articular injection of etanercept in patient suffering from rheumatoid arthritis: a double-blind randomized study for evaluation of efficacy and safety of etanercept versus intra-articular steroid injection in acute synovitis (knee,wrist,ankle,elbow)

Interventions

PROCEDUREintra-articular injection of etanercept
PROCEDUREintra-articular injection of steroid

Sponsors

Centre Hospitalier Universitaire de Nice
Lead SponsorOTHER
Wyeth is now a wholly owned subsidiary of Pfizer
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* must be able to understand the information about the study * diagnosis of rheumatoid arthritis for 6 month at least * suffering for 2 weeks at least * with evaluation of pain over 4/10 * with stable DMARDs treatment for three month at least

Exclusion criteria

* infection or surgery on the target joint * treated with infliximab,adalimumab or anakinra

Design outcomes

Primary

MeasureTime frame
Painevery month during six month

Countries

France

Contacts

PRINCIPAL_INVESTIGATORChristian H ROUX

Rheumatology department, Nice

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026